The Journal of Urology
Volume 180, Issue 6 , Pages 2569-2576, December 2008

Clinical and Consumer Trial Performance of a Sensitive Immunodiagnostic Home Test That Qualitatively Detects Low Concentrations of Sperm Following Vasectomy

  • Kenneth L. Klotz

      Affiliations

    • Department of Cell Biology and Center for Research in Contraceptive and Reproductive Health, University of Virginia, Charlottesville, Virginia
    • Financial interest and/or other relationship with ContraVac, Inc.
  • ,
  • Michael A. Coppola

      Affiliations

    • ContraVac, Inc., Charlottesville, Virginia
    • Financial interest and/or other relationship with ContraVac, Inc.
  • ,
  • Michel Labrecque

      Affiliations

    • Université Laval, Quebec, Canada
    • Financial interest and/or other relationship with ContraVac, Inc.
  • ,
  • Victor M. Brugh III

      Affiliations

    • Devine-Tidewater Urology, Virginia Beach, Virginia
  • ,
  • Kim Ramsey

      Affiliations

    • Devine-Tidewater Urology, Virginia Beach, Virginia
  • ,
  • Kyung-ah Kim

      Affiliations

    • Princeton BioMeditech Corp., Princeton, New Jersey
  • ,
  • Mark R. Conaway

      Affiliations

    • Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia
  • ,
  • Stuart S. Howards

      Affiliations

    • Department of Urology, University of Virginia, Charlottesville, Virginia
    • Financial interest and/or other relationship with ContraVac, Inc.
  • ,
  • Charles J. Flickinger

      Affiliations

    • Department of Cell Biology and Center for Research in Contraceptive and Reproductive Health, University of Virginia, Charlottesville, Virginia
    • Financial interest and/or other relationship with ContraVac, Inc.
  • ,
  • John C. Herr

      Affiliations

    • Department of Cell Biology and Center for Research in Contraceptive and Reproductive Health, University of Virginia, Charlottesville, Virginia
    • Financial interest and/or other relationship with ContraVac, Inc.
    • Corresponding Author InformationCorrespondence: Department of Cell Biology and Center for Contraceptive and Reproductive Health, P.O. Box 800732, University of Virginia Health System, Charlottesville, Virginia 22908-0732

Received 26 March 2008 published online 20 October 2008.

Purpose

Compliance with post-vasectomy semen analysis could be improved with the availability of a simple, rapid and accurate home test. SpermCheck Vasectomy®, a highly sensitive lateral flow immunochromatographic diagnostic device, was designed to detect extreme oligospermia or azoospermia in men after vasectomy. We report the results of clinical and consumer testing of SpermCheck.

Materials and Methods

A prospective, noncomparative observational study assessed the ability of SpermCheck Vasectomy to predict post-vasectomy sperm counts obtained using a hemacytometer procedure based on standard World Health Organization methodology. Consumer studies evaluated ease of use.

Results

A cohort of 144 post-vasectomy semen samples was tested in the clinical trial. SpermCheck was 96% accurate in predicting whether sperm counts were greater or less than a threshold of 250,000 sperm per ml, a level associated with little or no risk of pregnancy. Sensitivity was 93% (95% CI 79% to 98%) and specificity was 97% (91% to 99%). The positive predictive value of the test was 93% (79% to 98%), and most importantly the negative predictive value was 97% (91% to 99%). The test gave a positive result 100% of the time at sperm concentrations of 385,000/ml or greater. Consumer studies with 109 lay volunteers showed that SpermCheck was easy to use. Volunteers obtained the correct or expected test result in every case and the correct response rate on a 20 question survey about the test was 97%.

Conclusions

SpermCheck Vasectomy, a simple and reliable immunodiagnostic test that can provide evidence of vasectomy success or failure, offers a useful alternative to improve compliance with post-vasectomy sperm monitoring. It is currently the only Food and Drug Administration approved test for this purpose.

Key Words: vasectomy, spermatozoa, cytology, sperm count, instrumentation

Abbreviations and Acronyms: NPV, negative predictive value, PPV, positive predictive value, SP-10, sperm protein 10 [ARCV1 gene product]

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received institutional review board approval.

 Supported by National Institutes of Health Grant U54 29099, Fogarty International Center Grant D43 TW/HD 00654 and research contracts from ContraVac, Inc. (to JCH) with manufacturing and development expenses underwritten by Princeton BioMeditech Corporation.

 For another article on a related topic see page 2706.

PII: S0022-5347(08)02173-3

doi:10.1016/j.juro.2008.08.045

Refers to article:

  • Septins as Diagnostic Markers for a Subset of Human Asthenozoospermia , 24 October 2008

    Yoshio Sugino, Kentaro Ichioka, Takeshi Soda, Masafumi Ihara, Makoto Kinoshita, Osamu Ogawa, Hiroyuki Nishiyama
    The Journal of Urology December 2008 (Vol. 180, Issue 6, Pages 2706-2709)

The Journal of Urology
Volume 180, Issue 6 , Pages 2569-2576, December 2008